Twins Have Less Fat Accumulation Than Singletons Beginning in Early Pregnancy

Medically reviewed by Carmen Pope, BPharm. Last updated on April 17, 2025.

By Lori Solomon HealthDay Reporter

THURSDAY, April 17, 2025 -- Twins have proportionally less fat tissue accumulation in utero compared with singletons as early as 15 weeks of gestation, according to a study published online April 7 in JAMA Pediatrics.

Jessica L. Gleason, Ph.D., from the Eunice Kennedy Shriver National Institute of Child Health and Human Development in Bethesda, Maryland, and colleagues evaluated longitudinal fetal soft tissue development. The analysis included data from ultrasound scans at 15 to 37 weeks of gestation from 2,604 singleton and 171 twin pregnancies (315 fetuses).

The researchers found that mean twin abdominal measurements were significantly smaller than those of singletons between 25 and 37 weeks of gestation for area (difference at 25 weeks, −48.6 mm2; difference at 37 weeks, −480.5 mm2) and between 27 and 37 weeks for maximum abdominal subcutaneous tissue thickness (difference at 27 weeks, −0.13 mm; difference at 37 weeks, −0.40 mm). Fractional thigh volumes were significantly smaller for twins (mean fractional thigh volume difference, −0.11 cm3; mean fractional fat thigh volume difference, −0.08 cm3) relative to singletons, beginning at 15 weeks and persisting through 37 weeks (mean fractional thigh volume difference, −7.55 cm3; mean fractional fat thigh volume difference, −5.60 cm3). Similarly, mean fractional lean thigh volume was significantly smaller for twins at 15 to 16 and 23 to 36 weeks. Compared with singletons, for the ratio of fractional fat thigh volume to fractional thigh volume, twins had a 2.7 to 4.2 percent smaller fat percentage between 15 and 37 weeks.

"Persistent findings of smaller twin sizes and less fat accumulation across pregnancy support the concept of an early evolutionary adaptive process in otherwise uncomplicated dichorionic twin growth," the authors write.

Several authors disclosed ties to relevant organizations.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords